Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia Sericata Medical Maggots
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Babela Massiliensis, a Representative of a Widespread Bacterial
Babela massiliensis, a representative of a widespread bacterial phylum with unusual adaptations to parasitism in amoebae Isabelle Pagnier, Natalya Yutin, Olivier Croce, Kira S Makarova, Yuri I Wolf, Samia Benamar, Didier Raoult, Eugene V. Koonin, Bernard La Scola To cite this version: Isabelle Pagnier, Natalya Yutin, Olivier Croce, Kira S Makarova, Yuri I Wolf, et al.. Babela mas- siliensis, a representative of a widespread bacterial phylum with unusual adaptations to parasitism in amoebae. Biology Direct, BioMed Central, 2015, 10 (13), 10.1186/s13062-015-0043-z. hal-01217089 HAL Id: hal-01217089 https://hal-amu.archives-ouvertes.fr/hal-01217089 Submitted on 19 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Pagnier et al. Biology Direct (2015) 10:13 DOI 10.1186/s13062-015-0043-z RESEARCH Open Access Babela massiliensis, a representative of a widespread bacterial phylum with unusual adaptations to parasitism in amoebae Isabelle Pagnier1, Natalya Yutin2, Olivier Croce1, Kira S Makarova2, Yuri I Wolf2, Samia Benamar1, Didier Raoult1, Eugene V Koonin2 and Bernard La Scola1* Abstract Background: Only a small fraction of bacteria and archaea that are identifiable by metagenomics can be grown on standard media. -
(12) United States Patent (10) Patent No.: US 6,395,889 B1 Robison (45) Date of Patent: May 28, 2002
USOO6395889B1 (12) United States Patent (10) Patent No.: US 6,395,889 B1 Robison (45) Date of Patent: May 28, 2002 (54) NUCLEIC ACID MOLECULES ENCODING WO WO-98/56804 A1 * 12/1998 ........... CO7H/21/02 HUMAN PROTEASE HOMOLOGS WO WO-99/0785.0 A1 * 2/1999 ... C12N/15/12 WO WO-99/37660 A1 * 7/1999 ........... CO7H/21/04 (75) Inventor: fish E. Robison, Wilmington, MA OTHER PUBLICATIONS Vazquez, F., et al., 1999, “METH-1, a human ortholog of (73) Assignee: Millennium Pharmaceuticals, Inc., ADAMTS-1, and METH-2 are members of a new family of Cambridge, MA (US) proteins with angio-inhibitory activity', The Journal of c: - 0 Biological Chemistry, vol. 274, No. 33, pp. 23349–23357.* (*) Notice: Subject to any disclaimer, the term of this Descriptors of Protease Classes in Prosite and Pfam Data patent is extended or adjusted under 35 bases. U.S.C. 154(b) by 0 days. * cited by examiner (21) Appl. No.: 09/392, 184 Primary Examiner Ponnathapu Achutamurthy (22) Filed: Sep. 9, 1999 ASSistant Examiner William W. Moore (51) Int. Cl." C12N 15/57; C12N 15/12; (74) Attorney, Agent, or Firm-Alston & Bird LLP C12N 9/64; C12N 15/79 (57) ABSTRACT (52) U.S. Cl. .................... 536/23.2; 536/23.5; 435/69.1; 435/252.3; 435/320.1 The invention relates to polynucleotides encoding newly (58) Field of Search ............................... 536,232,235. identified protease homologs. The invention also relates to 435/6, 226, 69.1, 252.3 the proteases. The invention further relates to methods using s s s/ - - -us the protease polypeptides and polynucleotides as a target for (56) References Cited diagnosis and treatment in protease-mediated disorders. -
Serine Proteases with Altered Sensitivity to Activity-Modulating
(19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants. -
WO 2013/185113 Al 12 December 2013 (12.12.2013) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2013/185113 Al 12 December 2013 (12.12.2013) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 38/02 (2006.01) A61P 7/02 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 38/36 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) Number: International Application DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US20 13/044841 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, (22) International Filing Date: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 7 June 2013 (07.06.2013) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, (25) Filing Language: English SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (26) Publication Language: English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/657,688 8 June 2012 (08.06.2012) kind of regional protection available): ARIPO (BW, GH, 61/800,626 15 March 2013 (15.03.2013) GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (71) Applicant: BIOGEN IDEC MA INC. -
SUMO Protease 1 (GST-Tagged) from Yeast, Recombinant Cat
SUMO Protease 1 (GST-tagged) from Yeast, Recombinant Cat. No. NATE-1708 Lot. No. (See product label) Introduction Description SUMO (Small Ubiquitin-like MOdifiers) Protease 1 (Ulp1, Ubl-specific protease 1 from Saccharomyces cerevisiae) is a highly active cysteine protease. It is highly specific as it recognizes the tertiary structure of the ubiquitin-like (UBL) protein, SUMO (Smt3), rather than its amino acid sequence. SUMO fusion tag, as an N-terminal fusion partner, has been shown to enhance functional protein production in prokaryotic and eukaryotic expression systems with significantly improved protein stability and solubility. The SUMO protease 1 can be used to cleave SUMO protein tag from recombinant SUMO-fusion proteins. The optimal temperature for cleavage is 30°C; however, the enzyme is active over wide ranges of temperature and pH. After the completion of the cleavage reaction, the protease can be easily removed from the reaction by affinity chromatography using the Glutathione resin. Synonyms Ulp1 peptidase; SUMO Protease; SUMO Protease Product Information Species Yeast Source E. coli Form Liquid EC Number EC 3.4.22.68 Molecular Weight 52.6 kDa (403-621 aa + N-terminal GST). Purity > 90% by SDS-PAGE Activity >10,000 units/mg Concentration 1 mg/ml Unit Definition One unit is defined as the amount of SUMO Protease 1 required to cleave >90% of 5 µg a control protein substrate (SUMO-GFP) in 1 h at 37°C. Creative Enzymes. All rights reserved. 45-1 Ramsey Road, Shirley, NY 11967, USA Tel:1-631-562-8517 1-516-512-3133 Fax:1-631-938-8127 E-mail: [email protected] http://www.creative-enzymes.com Notes INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. -
Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases
Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases Alan J. Barrett Neil D. Rawlings J. Fred Woessner Editor biographies xxi Contributors xxiii Preface xxxi Introduction ' Abbreviations xxxvii ASPARTIC PEPTIDASES Introduction 1 Aspartic peptidases and their clans 3 2 Catalytic pathway of aspartic peptidases 12 Clan AA Family Al 3 Pepsin A 19 4 Pepsin B 28 5 Chymosin 29 6 Cathepsin E 33 7 Gastricsin 38 8 Cathepsin D 43 9 Napsin A 52 10 Renin 54 11 Mouse submandibular renin 62 12 Memapsin 1 64 13 Memapsin 2 66 14 Plasmepsins 70 15 Plasmepsin II 73 16 Tick heme-binding aspartic proteinase 76 17 Phytepsin 77 18 Nepenthesin 85 19 Saccharopepsin 87 20 Neurosporapepsin 90 21 Acrocylindropepsin 9 1 22 Aspergillopepsin I 92 23 Penicillopepsin 99 24 Endothiapepsin 104 25 Rhizopuspepsin 108 26 Mucorpepsin 11 1 27 Polyporopepsin 113 28 Candidapepsin 115 29 Candiparapsin 120 30 Canditropsin 123 31 Syncephapepsin 125 32 Barrierpepsin 126 33 Yapsin 1 128 34 Yapsin 2 132 35 Yapsin A 133 36 Pregnancy-associated glycoproteins 135 37 Pepsin F 137 38 Rhodotorulapepsin 139 39 Cladosporopepsin 140 40 Pycnoporopepsin 141 Family A2 and others 41 Human immunodeficiency virus 1 retropepsin 144 42 Human immunodeficiency virus 2 retropepsin 154 43 Simian immunodeficiency virus retropepsin 158 44 Equine infectious anemia virus retropepsin 160 45 Rous sarcoma virus retropepsin and avian myeloblastosis virus retropepsin 163 46 Human T-cell leukemia virus type I (HTLV-I) retropepsin 166 47 Bovine leukemia virus retropepsin 169 48 -
Biochemical Investigation of the Ubiquitin Carboxyl-Terminal Hydrolase Family" (2015)
Purdue University Purdue e-Pubs Open Access Dissertations Theses and Dissertations Spring 2015 Biochemical investigation of the ubiquitin carboxyl- terminal hydrolase family Joseph Rashon Chaney Purdue University Follow this and additional works at: https://docs.lib.purdue.edu/open_access_dissertations Part of the Biochemistry Commons, Biophysics Commons, and the Molecular Biology Commons Recommended Citation Chaney, Joseph Rashon, "Biochemical investigation of the ubiquitin carboxyl-terminal hydrolase family" (2015). Open Access Dissertations. 430. https://docs.lib.purdue.edu/open_access_dissertations/430 This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact [email protected] for additional information. *UDGXDWH6FKRRO)RUP 8SGDWHG PURDUE UNIVERSITY GRADUATE SCHOOL Thesis/Dissertation Acceptance 7KLVLVWRFHUWLI\WKDWWKHWKHVLVGLVVHUWDWLRQSUHSDUHG %\ Joseph Rashon Chaney (QWLWOHG BIOCHEMICAL INVESTIGATION OF THE UBIQUITIN CARBOXYL-TERMINAL HYDROLASE FAMILY Doctor of Philosophy )RUWKHGHJUHHRI ,VDSSURYHGE\WKHILQDOH[DPLQLQJFRPPLWWHH Chittaranjan Das Angeline Lyon Christine A. Hrycyna George M. Bodner To the best of my knowledge and as understood by the student in the Thesis/Dissertation Agreement, Publication Delay, and Certification/Disclaimer (Graduate School Form 32), this thesis/dissertation adheres to the provisions of Purdue University’s “Policy on Integrity in Research” and the use of copyrighted material. Chittaranjan Das $SSURYHGE\0DMRU3URIHVVRU V BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB $SSURYHGE\R. E. Wild 04/24/2015 +HDGRIWKH'HSDUWPHQW*UDGXDWH3URJUDP 'DWH BIOCHEMICAL INVESTIGATION OF THE UBIQUITIN CARBOXYL-TERMINAL HYDROLASE FAMILY Dissertation Submitted to the Faculty of Purdue University by Joseph Rashon Chaney In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy May 2015 Purdue University West Lafayette, Indiana ii All of this I dedicate wife, Millicent, to my faithful and beautiful children, Josh and Caleb. -
Geobacillus Lituanicus DSM 15325T Kolagenolizinės Peptidazės U32.002 Geno Transkripcijos Analizė Bei Klonavimas
VILNIAUS UNIVERSITETAS GAMTOS MOKSLŲ FAKULTETAS MIKROBIOLOGIJOS IR BIOTECHNOLOGIJOS KATEDRA Mikrobiologijos studijų programos magistrantas Andrius JASILIONIS Magistrinis darbas Geobacillus lituanicus DSM 15325T kolagenolizinės peptidazės U32.002 geno transkripcijos analizė bei klonavimas Darbo vadovė: dr. Nomeda KUISIENĖ Vilnius 2011 Geobacillus lituanicus DSM 15325T kolagenolizinės peptidazės U32.002 geno transkripcijos analizė bei klonavimas Darbas atliktas Vilniaus universiteto Gamtos mokslų fakulteto Mikrobiologijos ir biotechnologijos katedroje Andrius JASILIONIS Darbo vadovė: Nomeda KUISIENĖ 2 TURINYS SANTRUMPŲ SĄRAŠAS // 4 ĮVADAS // 5 1. LITERATŪROS APŢVALGA 1.1 Kolagenai - kolagenolizės substratai // 6 1.2 Kolagenolizinės peptidazės // 10 1.2.1 Eukariotų kolagenoliziniai fermentai // 13 1.2.2 Prokariotų kolagenoliziniai fermentai // 15 1.2.2.1 U32 kolagenolizinių peptidazių šeima // 18 1.3 Kolagenolizė: bendrasis modelis // 23 1.4 Praktinė kolagenolizės svarba // 24 2. METODAI 2.1 Tirti kamienai // 26 2.2. Medţiagos 2.2.1 Medţiagos terpių ir buferių gamybai // 26 2.2.2 Komerciniai rinkiniai // 26 2.2.3 Medţiagos PGR ir nukleorūgščių vizualizavimui // 26 2.2.4 Kitos medţiagos // 27 2.3. Terpės 2.3.1 Terpės biomasės prieaugiui, palaikymui ir kultūros grynumo patikrinimui // 27 2.3.2 Skysta terpė kamieno kultivavimui vykdant transkripcijos analizę // 27 2.4 Metodai 2.4.1 Kultūros grynumo patikrinimas // 28 2.4.2 Suminės RNR preparatų iš G. lituanicus DSM 15325T išskyrimas // 28 2.4.3 kDNR sintezė // 29 2.4.4 U32.002 kolagenolizinės -
Babela Massiliensis, a Representative of A
Pagnier et al. Biology Direct (2015) 10:13 DOI 10.1186/s13062-015-0043-z RESEARCH Open Access Babela massiliensis, a representative of a widespread bacterial phylum with unusual adaptations to parasitism in amoebae Isabelle Pagnier1, Natalya Yutin2, Olivier Croce1, Kira S Makarova2, Yuri I Wolf2, Samia Benamar1, Didier Raoult1, Eugene V Koonin2 and Bernard La Scola1* Abstract Background: Only a small fraction of bacteria and archaea that are identifiable by metagenomics can be grown on standard media. Recent efforts on deep metagenomics sequencing, single-cell genomics and the use of specialized culture conditions (culturomics) increasingly yield novel microbes some of which represent previously uncharacterized phyla and possess unusual biological traits. Results: We report isolation and genome analysis of Babela massiliensis, an obligate intracellular parasite of Acanthamoeba castellanii. B. massiliensis shows an unusual, fission mode of cell multiplication whereby large, polymorphic bodies accumulate in the cytoplasm of infected amoeba and then split into mature bacterial cells. This unique mechanism of cell division is associated with a deep degradation of the cell division machinery and delayed expression of the ftsZ gene. The genome of B. massiliensis consists of a circular chromosome approximately 1.12 megabase in size that encodes, 981 predicted proteins, 38 tRNAs and one typical rRNA operon. Phylogenetic analysis shows that B. massiliensis belongs to the putative bacterial phylum TM6 that so far was represented by the draft genome of the JCVI TM6SC1 bacterium obtained by single cell genomics and numerous environmental sequences. Conclusions: Currently, B. massiliensis is the only cultivated member of the putative TM6 phylum. Phylogenomic analysis shows diverse taxonomic affinities for B. -
2007 Ciências Básicas Moleculares
XV Congresso de Iniciação Científica da UNIFESP – 2007 Ciências Básicas Moleculares UNIVERSIDADE FEDERAL DE SÃO PAULO ESCOLA PAULISTA DE MEDICINA XV CONGRESSO DE INICIAÇÃO CIENTÍFICA REITOR Prof. Dr. Ulysses Fagundes Neto VICE-REITOR Prof. Dr. Sergio Tufik PRÓ-REITORIAS Graduação Prof. Dr. Luiz Eugênio Araújo de Moraes Mello Pós-Graduação e Pesquisa Prof. Dr. Nestor Schor Extensão Prof. Dr. Walter Manna Albertoni Administração Prof. Dr. Sérgio Antonio Draibe 1 XV Congresso de Iniciação Científica da UNIFESP – 2007 Ciências Básicas Moleculares COMISSÃO ORGANIZADORA COORDENAÇÃO DO PIBIC - CONGRESSO Profa. Dra. Helena Bonciani Nader Profa. Dra. Lucia de Oliveira Sampaio Prof. Dr. Luiz Eugênio Araújo de Moraes Mello COMISSÃO INSTITUCIONAL DE INICIAÇÃO CIENTÍFICA Comitê Institucional Profa. Dra. Adriana Karaoglanovic Carmona Prof. Dr. Angelo Amato Vincenzo de Paola Profa. Dra. Anita Hilda Straus Takahashi Profa. Dra. Brasília Maria Chiari Profa. Dra. Clara Lucia Barbieri Mestriner Profa. Dra. Clara Regina Brandão de Ávila Profa. Dra. Eliane Beraldi Ribeiro Profa. Dra. Emília Inoue Sato Profa. Dra. Heimar de Fátima Marin Profa. Dra. Ieda Maria Longo Maugeri Profa. Dra. Janete Maria Cerutti Profa. Dra. Janine Schirmer Prof. Dr. José Carlos Costa Baptista Silva Prof. Dr. José Maria Soares Júnior Prof. Dr. Luiz Roberto Ramos Prof. Dr. Manuel de Jesus Simões Profa. Dra. Mara Helena de Andréa Gomes Profa. Dra. Maria Gerbase de Lima Profa. Dra. Marília de Arruda Cardoso Smith Profa. Dra. Neusa Pereira da Silva Prof. Dr. Reynaldo Jesus Garcia Filho Prof. Dr. Roberto Frussa Filho Profa. Dra. Rosana Fiorini Puccini Prof. Dr. Sang Won Han Profa. Dra. Sima Godosevicius Katz Comitê Externo Prof. Dr. Eder Carlos Rocha Quintão Prof. -
(12) Patent Application Publication (10) Pub. No.: US 2004/0081648A1 Afeyan Et Al
US 2004.008 1648A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0081648A1 Afeyan et al. (43) Pub. Date: Apr. 29, 2004 (54) ADZYMES AND USES THEREOF Publication Classification (76) Inventors: Noubar B. Afeyan, Lexington, MA (51) Int. Cl." ............................. A61K 38/48; C12N 9/64 (US); Frank D. Lee, Chestnut Hill, MA (52) U.S. Cl. ......................................... 424/94.63; 435/226 (US); Gordon G. Wong, Brookline, MA (US); Ruchira Das Gupta, Auburndale, MA (US); Brian Baynes, (57) ABSTRACT Somerville, MA (US) Disclosed is a family of novel protein constructs, useful as Correspondence Address: drugs and for other purposes, termed “adzymes, comprising ROPES & GRAY LLP an address moiety and a catalytic domain. In Some types of disclosed adzymes, the address binds with a binding site on ONE INTERNATIONAL PLACE or in functional proximity to a targeted biomolecule, e.g., an BOSTON, MA 02110-2624 (US) extracellular targeted biomolecule, and is disposed adjacent (21) Appl. No.: 10/650,592 the catalytic domain So that its affinity Serves to confer a new Specificity to the catalytic domain by increasing the effective (22) Filed: Aug. 27, 2003 local concentration of the target in the vicinity of the catalytic domain. The present invention also provides phar Related U.S. Application Data maceutical compositions comprising these adzymes, meth ods of making adzymes, DNA's encoding adzymes or parts (60) Provisional application No. 60/406,517, filed on Aug. thereof, and methods of using adzymes, Such as for treating 27, 2002. Provisional application No. 60/423,754, human Subjects Suffering from a disease, Such as a disease filed on Nov. -
Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer
Hindawi Journal of the Renin-Angiotensin-Aldosterone System Volume 2021, Article ID 9987115, 17 pages https://doi.org/10.1155/2021/9987115 Research Article Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer Danial Mehranfard ,1 Gabriela Perez,2 Andres Rodriguez,3 Julia M. Ladna,4 Christopher T. Neagra,5 Benjamin Goldstein,6 Timothy Carroll,7 Alice Tran,8 Malav Trivedi,1 and Robert C. Speth 1 1College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA 2Department of Internal Medicine, Palmetto General Hospital, Hialeah, FL, USA 3Department of Internal Medicine, University of Miami/Jackson Memorial Hospital, Miami, FL, USA 4Broward Health Medical Center, Fort Lauderdale, FL, USA 5Baylor College of Medicine, Houston, TX, USA 6University of Florida, Gainesville, FL, USA 7College of Psychology, Nova Southeastern University, Fort Lauderdale, FL, USA 8Halmos College of Arts and Sciences, Nova Southeastern University, Fort Lauderdale, FL, USA Correspondence should be addressed to Robert C. Speth; [email protected] Received 2 February 2021; Revised 13 May 2021; Accepted 7 June 2021; Published 6 July 2021 Academic Editor: Peter Sever Copyright © 2021 Danial Mehranfard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Hypothesis/Introduction. Recent studies suggest involvement of the renin-angiotensin system (RAS) in cancers, including colorectal cancer (CRC). This study focuses on the association of genes encoding 17 proteins related to the RAS within a Japanese male CRC population. Materials and Methods. Quantitative expression of the RNA of these 17 genes in normal and cancerous tissues obtained using chip arrays from the public functional genomics data repository, Gene Expression Omnibus (GEO) application, was compared statistically.